These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 18465074)

  • 1. Soluble RANKL induces high bone turnover and decreases bone volume, density, and strength in mice.
    Lloyd SA; Yuan YY; Kostenuik PJ; Ominsky MS; Lau AG; Morony S; Stolina M; Asuncion FJ; Bateman TA
    Calcif Tissue Int; 2008 May; 82(5):361-72. PubMed ID: 18465074
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the effects of genistein and zoledronic acid on the bone loss in OPG-deficient mice.
    Liu J; Xu K; Wen G; Guo H; Li S; Wu X; Dai R; Sheng Z; Liao E
    Bone; 2008 May; 42(5):950-9. PubMed ID: 18337202
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anabolic action of parathyroid hormone is skeletal site specific at the tissue and cellular levels in mice.
    Iida-Klein A; Zhou H; Lu SS; Levine LR; Ducayen-Knowles M; Dempster DW; Nieves J; Lindsay R
    J Bone Miner Res; 2002 May; 17(5):808-16. PubMed ID: 12009011
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased RANK ligand in bone marrow of orchiectomized rats and prevention of their bone loss by the RANK ligand inhibitor osteoprotegerin.
    Li X; Ominsky MS; Stolina M; Warmington KS; Geng Z; Niu QT; Asuncion FJ; Tan HL; Grisanti M; Dwyer D; Adamu S; Ke HZ; Simonet WS; Kostenuik PJ
    Bone; 2009 Oct; 45(4):669-76. PubMed ID: 19539794
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Denosumab, a fully human RANKL antibody, reduced bone turnover markers and increased trabecular and cortical bone mass, density, and strength in ovariectomized cynomolgus monkeys.
    Ominsky MS; Stouch B; Schroeder J; Pyrah I; Stolina M; Smith SY; Kostenuik PJ
    Bone; 2011 Aug; 49(2):162-73. PubMed ID: 21497676
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Skeletal deterioration induced by RANKL infusion: a model for high-turnover bone disease.
    Yuan YY; Kostenuik PJ; Ominsky MS; Morony S; Adamu S; Simionescu DT; Basalyga DM; Asuncion FJ; Bateman TA
    Osteoporos Int; 2008 May; 19(5):625-35. PubMed ID: 18038244
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Administration of high-dose macrophage colony-stimulating factor increases bone turnover and trabecular volume fraction.
    Lloyd SA; Yuan YY; Simske SJ; Riffle SE; Ferguson VL; Bateman TA
    J Bone Miner Metab; 2009; 27(5):546-54. PubMed ID: 19326045
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-fat diet decreases cancellous bone mass but has no effect on cortical bone mass in the tibia in mice.
    Cao JJ; Gregoire BR; Gao H
    Bone; 2009 Jun; 44(6):1097-104. PubMed ID: 19264159
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decreased bone remodeling and porosity are associated with improved bone strength in ovariectomized cynomolgus monkeys treated with denosumab, a fully human RANKL antibody.
    Kostenuik PJ; Smith SY; Jolette J; Schroeder J; Pyrah I; Ominsky MS
    Bone; 2011 Aug; 49(2):151-61. PubMed ID: 21457806
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Osteoprotegerin is an effective countermeasure for spaceflight-induced bone loss in mice.
    Lloyd SA; Morony SE; Ferguson VL; Simske SJ; Stodieck LS; Warmington KS; Livingston EW; Lacey DL; Kostenuik PJ; Bateman TA
    Bone; 2015 Dec; 81():562-572. PubMed ID: 26318907
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bone quality is partially recovered after the discontinuation of RANKL administration in rats by increased bone mass on existing trabeculae: an in vivo micro-CT study.
    Campbell GM; Ominsky MS; Boyd SK
    Osteoporos Int; 2011 Mar; 22(3):931-42. PubMed ID: 20480144
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of strength training and raloxifene on bone health in aging ovariectomized rats.
    Stringhetta-Garcia CT; Singulani MP; Santos LF; Louzada MJ; Nakamune AC; Chaves-Neto AH; Rossi AC; Ervolino E; Dornelles RC
    Bone; 2016 Apr; 85():45-54. PubMed ID: 26812611
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Temporal changes in systemic and local expression of bone turnover markers during six months of sclerostin antibody administration to ovariectomized rats.
    Stolina M; Dwyer D; Niu QT; Villasenor KS; Kurimoto P; Grisanti M; Han CY; Liu M; Li X; Ominsky MS; Ke HZ; Kostenuik PJ
    Bone; 2014 Oct; 67():305-13. PubMed ID: 25093263
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of cyclic versus daily hPTH(1-34) regimens on bone strength in association with BMD, biochemical markers, and bone structure in mice.
    Iida-Klein A; Hughes C; Lu SS; Moreno A; Shen V; Dempster DW; Cosman F; Lindsay R
    J Bone Miner Res; 2006 Feb; 21(2):274-82. PubMed ID: 16418783
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does methamphetamine affect bone metabolism?
    Tomita M; Katsuyama H; Watanabe Y; Okuyama T; Fushimi S; Ishikawa T; Nata M; Miyamoto O
    Toxicology; 2014 May; 319():63-8. PubMed ID: 24582730
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased bone mass in mice after single injection of anti-receptor activator of nuclear factor-kappaB ligand-neutralizing antibody: evidence for bone anabolic effect of parathyroid hormone in mice with few osteoclasts.
    Furuya Y; Mori K; Ninomiya T; Tomimori Y; Tanaka S; Takahashi N; Udagawa N; Uchida K; Yasuda H
    J Biol Chem; 2011 Oct; 286(42):37023-31. PubMed ID: 21862583
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of Fatigue Loading and Bone Turnover on Bone Strength and Pattern of Experimental Fractures of the Tibia in Mice.
    Bonnet N; Gerbaix M; Ominsky M; Ammann P; Kostenuik PJ; Ferrari SL
    Calcif Tissue Int; 2016 Jul; 99(1):99-109. PubMed ID: 26945756
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Short-term continuous infusion of human parathyroid hormone 1-34 fragment is catabolic with decreased trabecular connectivity density accompanied by hypercalcemia in C57BL/J6 mice.
    Iida-Klein A; Lu SS; Kapadia R; Burkhart M; Moreno A; Dempster DW; Lindsay R
    J Endocrinol; 2005 Sep; 186(3):549-57. PubMed ID: 16135674
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The RANKL inhibitor OPG-Fc increases cortical and trabecular bone mass in young gonad-intact cynomolgus monkeys.
    Ominsky MS; Kostenuik PJ; Cranmer P; Smith SY; Atkinson JE
    Osteoporos Int; 2007 Aug; 18(8):1073-82. PubMed ID: 17384898
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Receptor activator of NF-[kappa]B ligand arrests bone growth and promotes cortical bone resorption in growing rats.
    McHugh NA; Vercesi HM; Egan RW; Hey JA
    J Appl Physiol (1985); 2003 Aug; 95(2):672-6. PubMed ID: 12692138
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.